Discovery of antimicrobial compounds targeting bacterial type FAD synthetases

Sebastián, M. (Universidad de Zaragoza) ; Anoz-Carbonell, E. (Universidad de Zaragoza) ; Gracia, B. (Universidad de Zaragoza) ; Cossio, P. ; Aínsa, J.A. ; Lans, I. ; Medina, M. (Universidad de Zaragoza)
Discovery of antimicrobial compounds targeting bacterial type FAD synthetases
Resumen: The increase of bacterial strains resistant to most of the available antibiotics shows a need to explore novel antibacterial targets to discover antimicrobial drugs. Bifunctional bacterial FAD synthetases (FADSs) synthesise the flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These cofactors act in vital processes as part of flavoproteins, making FADS an essential enzyme. Bacterial FADSs are potential antibacterial targets because of differences to mammalian enzymes, particularly at the FAD producing site. We have optimised an activity-based high throughput screening assay targeting Corynebacterium ammoniagenes FADS (CaFADS) that identifies inhibitors of its different activities. We selected the three best high-performing inhibitors of the FMN:adenylyltransferase activity (FMNAT) and studied their inhibition mechanisms and binding properties. The specificity of the CaFADS hits was evaluated by studying also their effect on the Streptococcus pneumoniae FADS activities, envisaging differences that can be used to discover species-specific antibacterial drugs. The antimicrobial effect of these compounds was also evaluated on C. ammoniagenes, S. pneumoniae, and Mycobacterium tuberculosis cultures, finding hits with favourable antimicrobial properties.
Idioma: Inglés
DOI: 10.1080/14756366.2017.1411910
Año: 2018
Publicado en: Journal of Enzyme Inhibition and Medicinal Chemistry 33, 1 (2018), 241-254
ISSN: 1475-6366

Factor impacto JCR: 4.027 (2018)
Categ. JCR: CHEMISTRY, MEDICINAL rank: 9 / 61 = 0.148 (2018) - Q1 - T1
Categ. JCR: BIOCHEMISTRY & MOLECULAR BIOLOGY rank: 82 / 294 = 0.279 (2018) - Q2 - T1

Factor impacto SCIMAGO: 0.781 - Drug Discovery (Q2) - Pharmacology (Q2) - Medicine (miscellaneous) (Q2)

Financiación: info:eu-repo/grantAgreement/ES/DGA/B18
Financiación: info:eu-repo/grantAgreement/ES/MINECO/BIO2016-75183-P
Tipo y forma: Article (Published version)
Área (Departamento): Proy. investigación HQA (Dpto. Microb.Med.Pr.,Sal.Públ.)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Exportado de SIDERAL (2020-11-30-07:57:18)

Este artículo se encuentra en las siguientes colecciones:

 Record created 2018-02-16, last modified 2020-11-30

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)